Atumelnant for Drug Interaction Study

This trial tests how the drug atumelnant interacts with other substances in the body. The researchers aim to understand how strong inducers of the enzyme CYP3A4 affect atumelnant and how atumelnant influences the processing of certain drugs. Healthy, non-smoking adults who can follow a structured diet and exercise routine might be a good fit. Participants will take atumelnant along with specific substances like midazolam, digoxin, and metformin. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this new treatment.

Yes, you will need to stop taking any drugs, including prescription and non-prescription medications, herbal remedies, and supplements, at least 14 days before the trial starts.

Research has shown that atumelnant is generally safe for people. Studies have found no serious side effects from this treatment. Earlier research indicated that most people tolerated it well. The most common side effects are mild to moderate, such as headaches and nausea. No severe unexpected medical issues were reported, suggesting that atumelnant is safe for human use.¹²³⁴⁵

Atumelnant is unique because it targets multiple pathways involved in drug interactions. Unlike standard treatments that often focus on a single pathway, Atumelnant works alongside other substances like midazolam, digoxin, and metformin to explore its effect on various drug-metabolizing enzymes and transporters. Researchers are excited because this could lead to a more comprehensive understanding of how Atumelnant interacts with other medications, potentially improving the safety and efficacy of multi-drug regimens.

Research has shown that atumelnant yields promising results for treating certain conditions. In earlier studies, atumelnant quickly and significantly reduced levels of adrenal androgens, hormones produced by the adrenal glands. Some patients experienced these benefits within two weeks, and the effects persisted with ongoing treatment. Additionally, atumelnant lowered cortisol levels, a hormone related to stress, in some patients. These findings suggest that atumelnant could help manage conditions related to hormone imbalances. In this trial, participants will be divided into two cohorts: one receiving atumelnant with carbamazepine, and the other receiving atumelnant with midazolam, digoxin, and metformin, to study drug interactions.¹⁶⁷⁸⁹